Hu-MTM Mice for Cytokine Release Syndrome

The Hu-M™ model is highly suited for evaluating and mitigating adverse immunologically related responses associated with therapeutics that affect their safety and efficacy. FDA and other regulatory agencies have recently issued guidance for immunogenicity assessment including evaluating therapeutics for cytokine release syndrome. HuMurine’s Hu-M™ mouse mimics human cytokine response and dysregulation as a result of administration of monoclonal antibodies.

Customizable studies available! For pricing and availability please contact us at info@humurine.com or call 909-859-1050.